DIRS.INFO The most relevant business & tech news

Blum turned to programs mostly in states where abortion access — and, by extension, abortion training — is likely to remain protected, like California, Colorado, and New Mexico. The AAMC analysis found the number of applicants to OB-GYN residency programs in abortion ban states dropped by 6.7%, compared with a 0.4% increase in states where abortion remains legal. For internal medicine, the drop observed in abortion ban states was over five times as much as in states where abortion is legal. The AAMC analysis notes that even in states with abortion bans, residency programs are filling their positions — mostly because there are more graduating medical students in the U.S. and abroad than there are residency slots. Stulberg and others worry that this self-selection away from states with abortion restrictions will exacerbate the shortages of physicians in rural and underserved areas.

Persons: — Isabella Rosario Blum, Blum, —, “, ”, Atul Grover, ” Jack Resneck Jr, Wade, Resneck, Beverly Gray, Gray, Duke, Rohini Kousalya Siva, Kousalya Siva, “ We’re, Debra Stulberg, Stulberg, Hannah Light, Olson, Dr, Sanjay Gupta Organizations: Health, —, Association of American Medical Colleges, KFF Health, OB, Research, Action Institute, American Medical Association, Duke University School of Medicine, MedStar Washington Hospital Center, Washington , D.C, D.C, American Medical Student Association, Department of Family Medicine, University of Chicago, University of California, CNN, CNN Health, Residents, KFF Locations: Arizona, California , Colorado, New Mexico . Arizona, Seattle, Midwest, U.S, North Carolina, Washington ,, Maryland , New Hampshire , New York, Washington, Virginia, Tennessee, San Francisco, California, New York

☆ CNN Exclusive: Adderall prescriptions have been filled less often amid ongoing shortage in the US
▼ + stars: | 2024-04-02 | by ( Deidre Mcphillips | ) edition.cnn.com time to read: +10 min

CNN —About 1 in every 10 people in the US who uses Adderall or similar combination drugs to treat attention-deficit/hyperactivity disorder (ADHD) has been affected by an ongoing shortage, a new analysis suggests. The US Food and Drug Administration announced that Adderall was in shortage in mid-October 2022, and the share of people with ADHD who filled their prescriptions for Adderall and related medications plunged in the following months. Patients were considered eligible for a monthly prescription fill if they had filled one within the previous two years. Prescriptions for medications used to treat ADHD surged during the Covid-19 pandemic, especially among young adults and women, one study found. But it’s been about a year and a half since she’s been able to fill her Adderall prescription in a “totally uneventful” way, she said.

Persons: Adderall, Robert Califf, Anne Milgram, David Goodman, ”, Mary Beth King, it’s, she’s, ” King, King, ” Goodman, John Mitchell, ” Mitchell, they’re, ’ ”, –, “, Dr, Sanjay Gupta, hasn’t Organizations: CNN, US Food and Drug Administration, Drug, of Psychiatry, Behavioral Sciences, Johns Hopkins School of Medicine, American Professional Society, New, Psychiatric Institute, Columbia University Irving Medical Center, Duke University School of Medicine, Get CNN, CNN Health Locations: Sweden

☆ Treating ADHD patients with medication linked to lower risk of death overall, study finds
▼ + stars: | 2024-03-12 | by ( Deidre Mcphillips | ) edition.cnn.com time to read: +4 min

And prescriptions for ADHD medications surged during the Covid-19 pandemic, especially among young adults and women. Treatment with ADHD medication especially reduced the risk of death from “unnatural” causes, including accidental injury, suicide and accidental poisoning such as drug overdose. While ADHD medications are relatively short-acting, experts say it’s important to consider the broader outcomes along with the immediate benefits. When it comes to “natural” causes of death such as medical conditions, however, the new study found that medication did not significantly affect mortality among ADHD patients. For these reasons, the link identified between treatment with medication and reduced mortality risk cannot be considered a direct cause-and-effect.

Persons: “, ”, John Mitchell, ” Mitchell, Dr, Sanjay Gupta, ” CNN’s Kristen Rogers Organizations: CNN, New, Psychiatric Institute, Columbia University Irving Medical Center, Duke University School of Medicine, CNN Health Locations: Sweden, United States

☆ Opinion: Here are the jobs AI will impact most
▼ + stars: | 2023-09-05 | by ( Bethany Cianciolo | Jessica Chia | ) edition.cnn.com time to read: +42 min

Dan’s research and teaching focus is on using AI for legal services and the regulation of AI in society. For instance, we can develop AI tools to help individuals understand their responsibilities and rights, and preserve and enforce those rights. People in businesses, large and small, are already using chatbots, AI assistants and other AI tools to help them comply with laws, regulations and internal policies. Additionally, new roles are emerging in the legal industry, such as legal engineers who build systems, legal data scientists and legal operations professionals. AI tools will then quickly re-optimize decisions associated with inventory shipments, staffing and promotions.

Persons: ” That’s, Dropbox, Goldman Sachs, isn’t, Erich S, Huang, ” Erich S, Huang I’ve, Regina Barzilay, Barzilay, Geoffrey Hinton, radiologists, —, ’, Daniel W, Linna, Dan, …, ” Daniel W, Refik, Anadol, ”, Adam Elmachtoub, Nisreen, Theodore Kim, don’t, ” Theodore Kim Moreover, Janis Joplin, Jackie Jormp, We’re, Baz Luhrmann’s “, Gatsby, That’s, Leonardo DiCaprio, mockbusters, Eirini, GitHub Copilot, Ashok Goel, Jill Watson, ” Ashok Goel, Kristen DiCerbo, Alireza, Davis Organizations: CNN, CNET, International Association of Machinists, Aerospace Workers, Informatics, Verily, Duke Health, Biomedical Informatics, Duke University School of Medicine, Adobe, Apple, Electrical Engineering, Computer Science Department, MIT, Jameel Clinic, Machine Learning, MacArthur, National Academy of Engineering, American Academy of Arts and Sciences, Northwestern’s Pritzker School of Law, McCormick School of Engineering, Northwestern University’s CS, Center, Better Housing, UCLA’s Department of Design Media Arts, The Museum, Modern Art, Centre Pompidou, Walt Disney Concert, Department of Industrial Engineering, Research, Columbia University, NBA, Spice, Digital Organisation and Society, Royal Holloway, University of London, UK Academy of Information Systems, Yale, Pixar, Technical, Writers Guild of America, SAG, Hollywood, YouTube, Tech, Developers, Georgia Institute of Technology, National AI, Adult, Education, US National Science Foundation, Georgia Tech, Khan Academy, Systems, Studies, Agricultural Engineering, University of California, university’s, Agriculture, Labor Locations: outplacement, Iceland

The updated Covid booster shot is proving to be effective at keeping people — especially older adults — out of the hospital, according to two new studies published Friday by the Centers for Disease Control and Prevention. Full coverage of the Covid-19 pandemicBoth studies looked at the impact the updated Covid booster shot has had since it was first recommended by the CDC on Sept. 1. Those who had received the updated booster were 84% less likely to be hospitalized with Covid, compared with people who had never had the Covid vaccine. The effectiveness was nearly identical — 83% — for people who had their last Covid shot more than a year ago. "There are 28 million people over the age of 65 that are eligible for this updated booster shot but haven’t gotten it," Link-Gelles said.

☆ Ivermectin — a drug once touted as a Covid treatment by conservatives — doesn't improve recovery much, clinical trial finds
▼ + stars: | 2022-10-24 | by ( Spencer Kimball | ) www.cnbc.com time to read: +3 min

Ivermectin, a drug once touted by conservatives as a treatment for Covid, does not meaningfully improve the recovery time for people with mild to moderate Covid-19, according a large clinical trial published in a peer-reviewed journal. Ivermectin has been approved to treat parasitic worms in humans, but it's primarily used as a dewormer for horses. "Among outpatients with mild to moderate COVID-19, treatment with ivermectin, compared with placebo, did not significantly improve time to recovery," the team of scientists led by Duke University School of Medicine wrote. The latest trial looked at 817 people who took ivermectin tablets for three days and compared them to 774 who received a placebo. The participants who took ivermectin received a daily dose based on their weight.

Search resuls for: "Duke University School of Medicine"

6 mentions found